CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 target
Drug / intervention
propofol +4 moredrug
Likely dose
propofol 2mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00706277
NCT00706277Phase 4Completed
CompareCT.gov

Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function

Medical University Innsbruck·interventional·Posted Jun 27, 2008·Updated Feb 10, 2009

In Brief

A Phase 4 clinical trial evaluating propofol, remifentanil, and 2 other interventions for Lung Function. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The aim of the study is to investigate the effects of total intravenous anesthesia (TIVA; propofol, remifentanil) and balanced anesthesia (BAL; induction with propofol and fentanyl; maintenance of anesthesia with sevoflurane and nitrous oxide) on pulmonary function 30 minutes after emergence from the general anesthesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Function
CountriesAustria
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 27, 2008
Enrollment StartJun 1, 2008
Study CompletionDec 1, 2008
TodayJul 2, 2026
Posted 18.0 years ago

Interventions

propofoldrug

propofol 2mg/kg for induction of anesthesia; followed by propofol 6 mg/kg/hour

propofoldrug

propofol 2mg

remifentanildrug

remifentanil 0,25mcg/kg/hour

fentanyldrug

fentanyl 100mcg

Sevoflurane/Nitrous Oxidedrug

maintenance of anesthesia with sevoflurane and nitrous oxide